Validation of the 5th edition of the World Health Organization and International Consensus Classification guidelines for TP53-mutated myeloid neoplasm in an independent international cohort

Mithun Vinod Shah(Mayo Clinic in Arizona), Devendra Hiwase(Australasian Leukaemia and Lymphoma Group), Antoine N. Saliba(Mayo Clinic in Arizona), Cecilia Y. Arana Yi(Mayo Clinic in Arizona), Aref Al‐Kali(Mayo Clinic), Abhishek A. Mangaonkar(Mayo Clinic in Arizona), C. R. Toop(Royal Adelaide Hospital), Ayalew Tefferi(Mayo Clinic in Arizona), Sharad Kumar(South Australia Pathology), Monika Kutyna(Royal Adelaide Hospital), James M. Foran(Memorial Sloan Kettering Cancer Center), Attilio Orazi(Texas Tech University), Hamish S. Scott(Centre for Cancer Biology), Aasiya Matin(Mayo Clinic in Arizona), Anmol Baranwal(Mayo Clinic in Arizona), Dariusz Ladon(South Australia Pathology), Kevin Hung(Royal Adelaide Hospital), Christopher N Hahn(South Australia Pathology), Chung Hoow Kok(South Australian Health and Medical Research Institute), Hassan B. Alkhateeb(Mayo Clinic), Mehrdad Hefazi(Mayo Clinic), Anna Brown(South Australia Pathology), Daniel A. Arber(Stanford University), Mrinal M. Patnaik(Mayo Clinic in Arizona), Patricia T. Greipp(Mayo Clinic), Talha Badar(Mayo Clinic in Florida), Rong He(Illinois College), Kebede H. Begna(Mayo Clinic), William J. Hogan(Mayo Clinic), Danièl Thomas(University of Adelaide), Danielle Rud(Mayo Clinic in Arizona), Gauri Wechalekar(Royal Adelaide Hospital), Dong Chen(Mayo Clinic in Arizona), Mark R. Litzow(Toyota Motor Corporation (Switzerland)), David T Yeung(South Australia Pathology), Peter Bardy(Royal Adelaide Hospital), Naseema Gangat(Mayo Clinic)
Blood Cancer Journal
May 7, 2025
Cited by 6


Related Papers